APAC Contract Research Organisation (CRO) Market - Product Image

APAC Contract Research Organisation (CRO) Market

  • ID: 3308444
  • Report
  • Region: Asia Pacific
  • 149 Pages
  • Frost & Sullivan
1 of 4
An Analysis of Trends Transforming the CRO Industry

FEATURED COMPANIES

  • Chiltern
  • Choice Pharma
  • Clinipace Worldwide
  • Covance
  • Pacific Clinical Research
  • Parexel
  • MORE
The research service presents an overview and analysis of the Asia-Pacific (APAC) contract research organisation (CRO) market and provides revenue forecasts by phase and therapeutic type. It discusses the major issues and challenges, unmet needs, and emerging trends in the market and covers the complete life cycle of the CRO industry, from pre-clinical trials to post marketing surveillance.

Moreover, it provides detailed information on support services such as central laboratory services, bio-analytics, and data management. The research service also analyses market drivers and restraints, and provides market engineering measurements and research and development trends.

The Asia-Pacific (APAC) CRO market was worth $ billion in 2014 and is expected to reach $ billion in 2019, expanding at a strong CAGR of % from 2014 to 2019.

Outsourcing to low-cost locations is likely to result in lesser margins in the short term, but in higher volume share. However, with increased capacity and scale, companies are expected to improve their margins during the rest of the forecast period.

Specialised services such as eClinical trial solutions, adaptive trial designs, and outcomes research are expected to transform the way clinical trials are performed currently.

Spending on R&D is growing tremendously in APAC, driven by increased globalisation of the pharmaceutical and biotechnology markets and low-cost advantage, which support volume growth.

The top eight companies accounted for% of the total APAC CRO market in 2014. Quintiles leads the market with% share, followed by Covance (%), PPD (%), Parexel ( %) and PRA Health Sciences (%).

Mergers and acquisitions (M&A) will continue to drive consolidation in the CRO market; larger companies will continue to expand through acquisition. The merger of Clinipace Worldwide with Choice Pharma (a Pan-Asian CRO company) and acquisition of Pacific Clinical Research (a Pan-Asian CRO company) by Chiltern are examples of aggressive expansion strategies.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Chiltern
  • Choice Pharma
  • Clinipace Worldwide
  • Covance
  • Pacific Clinical Research
  • Parexel
  • MORE
1. Executive Summary
  • Key Findings
  • Total CRO Market Size - By Stages of Clinical Development
  • Market Size Estimation Methodology
  • Scope and Segmentation
  • Key Questions This Study Will Answer
  • Total CRO Market Engineering Measurements
  • CEO’s Perspective
  • Key Companies to Watch
  • 3 Big Predictions
2. Market Overview
  • R&D Spending - Pharmaceutical Drug Development
  • Market Perspective
  • R&D Market Landscape
  • CRO Product Development and Commercialization
  • Total CRO Market Segmentation - By Stages of Clinical Development
  • Total CRO Market Segmentation - By Therapeutic Services
  • Key Market Trends
  • eClinical Solutions - An Overview
  • eClinical Solutions - Applications and Technologies
  • Rise of Virtual Business Models
3. Competitive Playbook
  • New Market Opportunities
  • Merger, Acquisition and Partnership Assessment
  • Competitive Matrix
4. Drivers, Restraints, and Trends
  • Market Drivers
  • Market Restraints
5. Forecasts and Trends - Total CRO Market
  • Forecast Assumptions
  • Total CRO Market Engineering Measurements
  • Total CRO Market - Revenue Forecast
  • Total CRO Market - Revenue Forecast Discussion
  • Key Market Trends
  • Key Market Trends Explained
6. Competitive Environment
  • Competitive Analysis - Market Share
  • Market Share Analysis
  • Competitive Environment
  • Competitive Analysis - Selected Key Market Participants
7. Pre-Clinical Trials Segment Breakdown
  • Pre-Clinical Trials Segment Overview
  • Pre-Clinical Trials Segment - Market Engineering Measurements
  • Pre-Clinical Trials Segment - Revenue Forecast
  • Pre-Clinical Trials Segment - Revenue Forecast Discussion
  • Pre-Clinical Trials Segment Key Trends
8. Phase I Trials Segment Breakdown
  • Phase I Trials Segment Overview
  • Phase I Trials Segment - Market Engineering Measurements
  • Phase I Trials Segment - Revenue Forecast
  • Phase I Trials Segment - Revenue Forecast Discussion
  • Phase I Trials Segment Key Trends
9. Phase II Trials Segment Breakdown
  • Phase II Trials Segment Overview
  • Phase II Trials Segment - Market Engineering Measurements
  • Phase II Trials Segment - Revenue Forecast
  • Phase II Trials Segment - Revenue Forecast Discussion
  • Phase II Trials Segment Key Trends*
10. Phase III Trials Segment Breakdown
  • Phase III Trials Segment Overview
  • Phase III Trials Segment - Market Engineering Measurements
  • Phase III Trials Segment - Revenue Forecast
  • Phase III Trials Segment - Revenue Forecast Discussion
  • Phase III Trials Segment Key Trends*
11. Phase IV Trials Segment Breakdown
  • Phase IV Trials Segment Overview
  • Phase IV Trials Segment - Market Engineering Measurements
  • Phase IV Trials Segment - Revenue Forecast
  • Phase IV Trials Segment - Revenue Forecast Discussion
  • Phase IV Trials Segment Key Trends
12. Data Management Segment Breakdown
  • Data Management Segment Overview
  • Data Management Segment - Market Engineering Measurements
  • Data Management Segment - Revenue Forecast
  • Data Management Segment - Revenue Forecast Discussion
  • Data Management Segment Key Trends
13. Biostatistics Segment Breakdown
  • Biostatistics Segment Overview
  • Biostatistics Segment - Market Engineering Measurements
  • Biostatistics Segment - Revenue Forecast
  • Biostatistics Segment - Revenue Forecast Discussion
  • Biostatistics Segment Key Trends
14. Pharmacovigilance Segment Breakdown
  • Pharmacovigilance Segment Overview
  • Pharmacovigilance Segment - Market Engineering Measurements
  • Pharmacovigilance Segment - Revenue Forecast
  • Pharmacovigilance Segment - Revenue Forecast Discussion
  • Pharmacovigilance Segment Key Trends
15. Health Economics and Outcomes Research (HEOR) Segment Breakdown
  • HEOR Segment Overview
  • HEOR Segment - Market Engineering Measurements
  • HEOR Segment - Revenue Forecast
  • HEOR Segment - Revenue Forecast Discussion
  • HEOR Segment Key Trends
16. Bio-Analytics Segment
  • Bio-Analytics Segment Overview
  • Bio-Analytics Segment - Market Engineering Measurements
  • Bio-Analytics Segment - Revenue Forecast
  • Bio-Analytics Segment - Revenue Forecast Discussion
  • Bio-Analytics Segment Key Trends
17. Central Laboratory Services Segment Breakdown
  • Central Laboratory Services Segment Overview
  • Central Laboratory Services Segment - Market Engineering Measurements
  • Central Laboratory Services Segment - Revenue Forecast
  • Central Laboratory Services Segment - Revenue Forecast Discussion
  • Central Laboratory Services Segment Key Trends
18. The Last Word
  • 3 Big Predictions
  • The Last Word - Discussion
  • Legal Disclaimer
19. Appendix
  • Market Engineering Methodology
  • Drivers Explained
  • Restraints Explained
  • List of Exhibits
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- Chiltern
- Choice Pharma
- Clinipace Worldwide
- Covance
- PPD
- PRA Health Sciences
- Pacific Clinical Research
- Parexel

Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll